Demars Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Sell |
17,988
-948,199
| -98% | -$43.9M | 0.32% | 30 |
|
|
2025
Q1 | $15.8M | Buy |
966,187
+84,545
| +10% | +$1.39M | 0.45% | 26 |
|
|
2024
Q4 | $15.6M | Buy |
+881,642
| New | +$15.6M | 0.5% | 26 |
|
|
2024
Q2 | – | Sell |
-5,153
| Closed | -$279K | – | 68 |
|
|
2024
Q1 | $279K | Sell |
5,153
-9,898
| -66% | -$537K | 0.14% | 57 |
|
|
2023
Q4 | $772K | Sell |
15,051
-62,519
| -81% | -$3.21M | 0.41% | 24 |
|
|
2023
Q3 | $4.5M | Buy |
77,570
+7,366
| +10% | +$428K | 2.58% | 8 |
|
|
2023
Q2 | $4.49M | Sell |
70,204
-347
| -0.5% | -$22.2K | 2.49% | 14 |
|
|
2023
Q1 | $4.89M | Buy |
70,551
+8,628
| +14% | +$598K | 2.69% | 8 |
|
|
2022
Q4 | $4.46M | Sell |
61,923
-4,231
| -6% | -$304K | 2.46% | 12 |
|
|
2022
Q3 | $4.7M | Buy |
66,154
+2,713
| +4% | +$193K | 2.79% | 6 |
|
|
2022
Q2 | $4.89M | Sell |
63,441
-6,541
| -9% | -$504K | 2.78% | 10 |
|
|
2022
Q1 | $5.11M | Buy |
69,982
+7,936
| +13% | +$580K | 2.57% | 9 |
|
|
2021
Q4 | $3.87M | Buy |
62,046
+4,082
| +7% | +$255K | 2.05% | 17 |
|
|
2021
Q3 | $3.43M | Buy |
57,964
+54,255
| +1,463% | +$3.21M | 2.02% | 21 |
|
|
2021
Q2 | $248K | Buy |
+3,709
| New | +$248K | 0.15% | 77 |
|